Insider Trading activities at Elevance Health, Inc. (ELV)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Elevance Health, Inc. (ELV) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Elevance Health, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1156039.

Total stock buying since 2015: $5,822,835.
Total stock sales since 2015: $314,811,815.
Total stock option exercises since 2015: $81,169,912.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Elevance Health, Inc.* (*ELV*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2025	9,700	$2,814,505	8,535	$3,521,611	0	$0
2024	0	$0	64,454	$32,496,763	7,516	$1,790,836
2023	0	$0	18,841	$8,445,619	0	$0
2022	0	$0	30,627	$14,311,300	12,498	$3,157,567
2021	3,000	$1,002,918	64,093	$22,520,600	38,093	$5,308,830
2020	7,600	$2,005,412	112,370	$32,381,875	52,895	$6,801,768
2019	0	$0	78,809	$22,813,659	38,795	$6,647,931
2018	0	$0	317,117	$75,441,696	241,654	$25,017,396
2017	0	$0	147,399	$28,282,904	134,060	$11,353,864
2016	0	$0	139,900	$18,841,435	24,482	$1,898,490
2015	0	$0	368,387	$55,754,353	291,486	$19,193,230

Table 2. Monthly summary of insider trading at *Elevance Health, Inc.* (*ELV*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2025-08	1,200	$374,580	0	$0	0	$0
2025-07	8,500	$2,439,925	0	$0	0	$0
2025-04	0	$0	4,588	$1,949,074	0	$0
2025-03	0	$0	3,947	$1,572,537	0	$0
2024-10	0	$0	7,417	$3,205,182	0	$0
2024-08	0	$0	753	$400,234	0	$0
2024-07	0	$0	34,305	$17,213,653	0	$0
2024-04	0	$0	20,310	$10,838,999	7,516	$1,790,836
2024-03	0	$0	916	$462,195	0	$0
2024-02	0	$0	753	$376,500	0	$0
2023-11	0	$0	1,055	$501,304	0	$0
2023-10	0	$0	64	$29,078	0	$0
2023-07	0	$0	310	$147,780	0	$0
2023-03	0	$0	17,412	$7,767,457	0	$0
2022-06	0	$0	6,748	$3,306,733	6,328	$1,775,750
2022-05	0	$0	990	$464,191	0	$0
2022-03	0	$0	20,126	$9,287,411	3,407	$706,292
2022-02	0	$0	2,763	$1,252,965	2,763	$675,525
2021-10	0	$0	1,150	$501,400	0	$0
2021-07	1,300	$499,668	0	$0	0	$0
2021-05	0	$0	1,308	$520,610	0	$0
2021-03	0	$0	61,635	$21,498,590	38,093	$5,308,830
2021-02	1,700	$503,250	0	$0	0	$0
2020-12	0	$0	5,833	$1,824,154	5,833	$857,042

Table 3. Detailed insider trading at *Elevance Health, Inc.* (*ELV*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2025-08-19	Devore Susan D. (Director)	Buy	1,200	312.15	374,580
2025-07-18	Boudreaux Gail (President and CEO)	Buy	8,500	287.05	2,439,925
2025-04-24	Kaye Mark (EVP & CFO)	Sale	4,588	424.82	1,949,074
2025-03-10	Penczek Ronald W (CAO & Controller)	Sale	443	415.13	183,902
2025-03-05	Kendrick Charles Morgan Jr (EVP & President, Commercial)	Sale	3,504	396.30	1,388,635
2024-10-18	Kendrick Charles Morgan Jr (EVP & President, Commercial)	Sale	7,417	432.14	3,205,182
2024-08-05	Peru Ramiro G (Director)	Sale	753	531.52	400,234
2024-07-22	Boudreaux Gail (President and CEO)	Sale	34,000	501.74	17,059,092
2024-07-19	Dixon Robert L Jr (Director)	Sale	305	506.76	154,561
2024-04-24	Norwood Felicia F (EVP & President,Gov Health Ben)	Sale	6,199	532.41	3,300,409
2024-04-24	Norwood Felicia F (EVP & President,Gov Health Ben)	Option Ex	2,043	238.27	486,785
2024-04-23	Norwood Felicia F (EVP & President,Gov Health Ben)	Sale	14,111	534.24	7,538,590
2024-04-23	Norwood Felicia F (EVP & President,Gov Health Ben)	Option Ex	5,473	238.27	1,304,051
2024-03-06	Penczek Ronald W (CAO & Controller)	Sale	916	504.58	462,195
2024-02-07	Peru Ramiro G (Director)	Sale	753	500.00	376,500
2023-11-30	Penczek Ronald W (CAO & Controller)	Sale	1,055	475.17	501,304
2023-10-24	Penczek Ronald W (CAO & Controller)	Sale	64	454.35	29,078
2023-07-21	Dixon Robert L Jr (Director)	Sale	310	476.71	147,780
2023-03-24	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	15,098	443.63	6,697,880
2023-03-09	Kendrick Charles Morgan Jr (EVP & President, Commercial)	Sale	2,314	462.22	1,069,577
2022-06-09	Kendrick Charles Morgan Jr (EVP & President, Commercial)	Sale	6,328	489.56	3,097,935
2022-06-09	Kendrick Charles Morgan Jr (EVP & President, Commercial)	Option Ex	6,328	280.62	1,775,750
2022-06-06	Dixon Robert L Jr	Sale	420	497.14	208,798
2022-05-19	Peru Ramiro G	Sale	990	468.88	464,191
2022-03-10	Haytaian Peter D (EVP & Pres., DBG & IngenioRx)	Sale	17,703	461.16	8,163,915
2022-03-10	Haytaian Peter D (EVP & Pres., DBG & IngenioRx)	Option Ex	1,848	131.80	243,566
2022-03-03	Penczek Ronald W (CAO & Controller)	Sale	2,423	463.68	1,123,496
2022-03-03	Penczek Ronald W (CAO & Controller)	Option Ex	1,559	296.81	462,726
2022-02-07	Penczek Ronald W (CAO & Controller)	Sale	2,763	453.48	1,252,965
2022-02-07	Penczek Ronald W (CAO & Controller)	Option Ex	2,763	244.49	675,525
2021-10-28	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	1,150	436.00	501,400
2021-07-23	Schneider Ryan M.	Buy	1,300	384.36	499,668
2021-05-24	Peru Ramiro G	Sale	1,308	398.02	520,610
2021-03-22	Haytaian Peter D (EVP & President, Commercial)	Sale	59,500	349.35	20,786,325
2021-03-22	Haytaian Peter D (EVP & President, Commercial)	Option Ex	38,093	139.37	5,308,830
2021-03-05	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	2,068	333.94	690,587
2021-03-04	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	67	323.56	21,678
2021-02-04	Schneider Ryan M.	Buy	1,700	296.03	503,250
2020-12-15	Haytaian Peter D (EVP & President, Commercial)	Sale	5,833	312.73	1,824,154
2020-12-15	Haytaian Peter D (EVP & President, Commercial)	Option Ex	5,833	146.93	857,042
2020-11-16	Haytaian Peter D (EVP & President, Commercial)	Sale	5,834	333.90	1,947,978
2020-11-16	Haytaian Peter D (EVP & President, Commercial)	Option Ex	1,708	123.85	211,535
2020-11-09	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	1,199	330.75	396,569
2020-11-03	Zielinski Thomas C (EVP & General Counsel)	Sale	9,175	292.35	2,682,265
2020-11-03	Zielinski Thomas C (EVP & General Counsel)	Option Ex	1,893	232.04	439,251
2020-10-15	Haytaian Peter D (EVP & President, Commercial)	Sale	5,834	292.05	1,703,837
2020-10-15	Haytaian Peter D (EVP & President, Commercial)	Option Ex	4,667	100.77	470,293
2020-10-09	Haytaian Peter D (EVP & President, Commercial)	Sale	1,167	295.00	344,265
2020-10-02	Haytaian Peter D (EVP & President, Commercial)	Sale	4,667	280.00	1,306,760
2020-10-02	Haytaian Peter D (EVP & President, Commercial)	Option Ex	4,667	95.11	443,855
2020-06-08	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	545	297.74	162,268
2020-06-08	Haytaian Peter D (EVP & President, Commercial)	Sale	14,001	300.00	4,200,300
2020-06-08	Haytaian Peter D (EVP & President, Commercial)	Option Ex	11,421	95.11	1,086,194
2020-06-08	Zielinski Thomas C (EVP & General Counsel)	Sale	6,358	297.70	1,892,776
2020-06-08	Peru Ramiro G	Sale	1,102	300.00	330,600
2020-05-27	Dixon Robert L Jr	Sale	1,102	284.59	313,618
2020-05-19	Hill Julie A	Sale	1,102	283.26	312,152
2020-05-15	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	18,261	275.36	5,028,257
2020-05-15	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	18,261	131.80	2,406,799
2020-04-30	Zielinski Thomas C (EVP & General Counsel)	Sale	19,306	278.54	5,377,396
2020-04-30	Zielinski Thomas C (EVP & General Counsel)	Option Ex	4,445	199.50	886,799
2020-04-16	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	16,884	270.00	4,558,680
2020-01-30	Boudreaux Gail (President and CEO)	Buy	7,600	263.87	2,005,412
2019-12-24	Haytaian Peter D (EVP & President, Commercial)	Sale	4,166	303.82	1,265,714
2019-12-20	Haytaian Peter D (EVP & President, Commercial)	Sale	4,167	303.32	1,263,934
2019-12-04	Zielinski Thomas C (EVP & General Counsel)	Sale	10,600	288.33	3,056,298
2019-12-04	Zielinski Thomas C (EVP & General Counsel)	Option Ex	7,509	169.12	1,269,922
2019-11-18	Haytaian Peter D (EVP & President, Commercial)	Sale	12,095	300.00	3,628,500
2019-11-18	Haytaian Peter D (EVP & President, Commercial)	Option Ex	3,762	61.88	232,792
2019-11-13	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	816	287.00	234,192
2019-11-13	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	816	232.04	189,344
2019-11-12	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	357	282.00	100,674
2019-11-12	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	357	166.97	59,608
2019-10-28	Haytaian Peter D (EVP & President, Commercial)	Sale	9,586	269.56	2,584,050
2019-07-26	Dixon Robert L Jr (Director)	Sale	520	294.11	152,937
2019-07-26	Hill Julie A (Director)	Sale	1,656	295.00	488,520
2019-06-11	Zielinski Thomas C (EVP & General Counsel)	Sale	8,826	283.92	2,505,877
2019-06-11	Zielinski Thomas C (EVP & General Counsel)	Option Ex	8,826	159.79	1,410,306
2019-05-30	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	763	279.00	212,877
2019-05-30	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	763	149.38	113,980
2019-05-21	Peru Ramiro G (Director)	Sale	1,656	275.00	455,400
2019-03-04	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	7,701	304.18	2,342,467
2019-03-04	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	1,362	146.93	200,118
2019-02-04	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	7,700	302.84	2,331,844
2019-02-04	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	7,700	146.93	1,131,361
2019-01-31	Hill Julie A (Director)	Sale	500	299.75	149,875
2019-01-18	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	7,700	265.00	2,040,500
2019-01-18	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	7,700	265.00	2,040,500
2018-12-27	Haytaian Peter D (EVP & President, Commercial)	Sale	3,000	255.99	767,970
2018-11-27	Haytaian Peter D (EVP & President, Commercial)	Sale	4,500	278.79	1,254,555
2018-11-08	Hill Julie A (Director)	Sale	500	287.25	143,625
2018-11-07	Zielinski Thomas C (EVP & General Counsel)	Sale	7,826	289.71	2,267,270
2018-11-07	Zielinski Thomas C (EVP & General Counsel)	Option Ex	7,826	176.94	1,384,708
2018-10-31	Haytaian Peter D (EVP & President, Commercial)	Sale	1,000	270.00	270,000
2018-10-26	Haytaian Peter D (EVP & President, Commercial)	Sale	3,500	268.22	938,770
2018-09-27	Haytaian Peter D (EVP & President, Commercial)	Sale	4,500	270.00	1,215,000
2018-09-06	Haytaian Peter D (EVP & President, Commercial)	Sale	2,936	270.00	792,720
2018-09-06	Haytaian Peter D (EVP & President, Commercial)	Option Ex	1,936	60.15	116,450
2018-09-04	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	763	265.56	202,622
2018-09-04	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	763	149.38	113,980
2018-08-27	Haytaian Peter D (EVP & President, Commercial)	Sale	3,500	266.10	931,350
2018-08-16	Hill Julie A (Director)	Sale	248	267.01	66,218
2018-05-25	Hill Julie A (Director)	Sale	1,000	233.00	233,000
2018-05-18	Dixon Robert L Jr (Director)	Sale	1,000	231.10	231,100
2018-05-18	Peru Ramiro G (Director)	Sale	2,248	231.57	520,569
2018-05-03	Griffin Brian T (EVP & CEO, IngenioRx)	Sale	59,421	224.84	13,359,920
2018-05-03	Griffin Brian T (EVP & CEO, IngenioRx)	Option Ex	59,421	124.97	7,425,664
2018-03-13	Zielinski Thomas C (EVP & General Counsel)	Sale	20,455	229.39	4,692,172
2018-03-13	Zielinski Thomas C (EVP & General Counsel)	Option Ex	20,455	138.51	2,833,283
2018-03-07	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	1,966	231.91	455,925
2018-03-07	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	979	148.57	145,447
2018-03-05	Gallina John E (EVP & Chief Financial Officer)	Sale	24,576	230.31	5,660,024
2018-03-05	Gallina John E (EVP & Chief Financial Officer)	Option Ex	18,371	103.91	1,908,893
2018-03-05	Swedish Joseph (Executive Chairman)	Sale	27,846	231.11	6,435,600
2018-02-01	Swedish Joseph (Executive Chairman)	Sale	64,403	245.15	15,788,073
2018-02-01	Swedish Joseph (Executive Chairman)	Option Ex	64,403	78.44	5,051,771
2018-01-11	Swedish Joseph (Executive Chairman)	Sale	67,500	235.53	15,898,275
2018-01-11	Swedish Joseph (Executive Chairman)	Option Ex	67,500	89.44	6,037,200
2018-01-04	Mccarthy Gloria M (EVP & Chief Transformation Officer)	Sale	14,429	229.88	3,316,938
2017-12-01	Swedish Joseph (Executive Chairman)	Sale	21,125	231.71	4,894,873
2017-12-01	Swedish Joseph (Executive Chairman)	Option Ex	21,125	67.44	1,424,670
2017-11-07	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	978	217.42	212,636
2017-11-07	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	978	148.57	145,298
2017-11-07	Hill Julie A (Director)	Sale	1,602	215.70	345,551
2017-11-01	Swedish Joseph (Chair, President & CEO)	Sale	21,125	210.16	4,439,630
2017-11-01	Swedish Joseph (Chair, President & CEO)	Option Ex	21,125	67.44	1,424,670
2017-10-02	Swedish Joseph (Chair, President & CEO)	Sale	21,125	190.85	4,031,811
2017-10-02	Swedish Joseph (Chair, President & CEO)	Option Ex	21,125	67.44	1,424,670
2017-09-01	Swedish Joseph (Chair, President & CEO)	Sale	21,125	196.85	4,158,456
2017-09-01	Swedish Joseph (Chair, President & CEO)	Option Ex	21,125	67.44	1,424,670
2017-08-10	Hill Julie A (Director)	Sale	524	190.80	99,979
2017-08-10	Zielinski Thomas C (EVP & General Counsel)	Sale	9,127	191.48	1,747,610
2017-08-10	Zielinski Thomas C (EVP & General Counsel)	Option Ex	9,127	108.35	988,910
2017-06-07	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	867	187.46	162,527
2017-06-07	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	867	146.93	127,388
2017-05-30	Peru Ramiro G (Director)	Sale	2,681	181.58	486,815
2017-05-24	Hill Julie A (Director)	Sale	555	180.56	100,210
2017-04-03	Mccarthy Gloria M (EVP & Chief Transformation Officer)	Sale	15,187	166.72	2,532,022
2017-04-03	Mccarthy Gloria M (EVP & Chief Transformation Officer)	Option Ex	14,271	89.44	1,276,398
2017-03-06	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	375	165.28	61,980
2017-03-03	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	354	165.85	58,712
2017-03-03	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	286	89.44	25,579
2017-03-02	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	403	166.81	67,224
2017-03-02	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	285	89.44	25,490
2017-03-02	Zielinski Thomas C (EVP & General Counsel)	Sale	22,936	166.51	3,819,073
2017-03-02	Zielinski Thomas C (EVP & General Counsel)	Option Ex	22,936	129.03	2,959,363
2017-03-01	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	810	166.44	134,816
2017-03-01	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	810	131.80	106,758
2017-01-09	Tomas Jose D. (EVP & Chief HR Officer)	Sale	6,500	142.92	928,979
2016-12-12	Swedish Joseph (Chair, President & CEO)	Sale	8,176	144.31	1,179,878
2016-11-22	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	820	138.29	113,397
2016-11-11	Swedish Joseph (Chair, President & CEO)	Sale	8,171	134.44	1,098,509
2016-11-10	Swedish Joseph (Chair, President & CEO)	Sale	16,342	130.00	2,124,460
2016-08-12	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	600	130.00	78,000
2016-08-12	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	600	89.44	53,664
2016-08-12	Swedish Joseph (Chair, President & CEO)	Sale	8,171	130.71	1,067,990
2016-08-10	Zielinski Thomas C (EVP & General Counsel)	Sale	5,254	128.83	676,872
2016-08-03	Penczek Ronald W (SVP, Chief Accounting Officer)	Sale	552	128.37	70,860
2016-08-03	Penczek Ronald W (SVP, Chief Accounting Officer)	Option Ex	552	75.66	41,764
2016-08-01	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	4,186	130.76	547,382
2016-08-01	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	4,186	89.44	374,395
2016-07-28	Ryan William J (Director)	Sale	3,125	133.15	416,093
2016-07-11	Swedish Joseph (Chair, President & CEO)	Sale	8,171	131.74	1,076,447
2016-07-01	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	4,786	131.32	628,521
2016-07-01	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	4,786	83.47	399,487
2016-06-29	Peru Ramiro G (Director)	Sale	3,125	130.00	406,250
2016-06-01	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	4,786	131.69	630,268
2016-06-01	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	4,786	83.47	399,487
2016-06-01	Swedish Joseph (Chair, President & CEO)	Sale	11,628	132.08	1,535,826
2016-05-02	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	4,786	141.18	675,663
2016-05-02	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	4,786	69.69	333,536
2016-05-02	Swedish Joseph (Chair, President & CEO)	Sale	11,626	141.18	1,641,358
2016-04-14	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	4,786	142.51	682,052
2016-04-14	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	4,786	61.88	296,157
2016-04-01	Swedish Joseph (Chair, President & CEO)	Sale	11,626	139.30	1,619,466
2016-03-11	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	7,557	139.73	1,055,939
2016-01-28	Swedish Joseph (Chair, President & CEO)	Sale	11,626	130.41	1,516,204
2015-12-28	Swedish Joseph (Chair, President & CEO)	Sale	11,626	139.79	1,625,198
2015-09-08	Deveydt Wayne S (EVP & Chief Financial Officer)	Sale	6,969	144.19	1,004,825
2015-09-08	Deveydt Wayne S (EVP & Chief Financial Officer)	Option Ex	6,969	61.88	431,241
2015-06-01	Peru Ramiro G (Director)	Sale	4,709	168.23	792,180
2015-05-28	Ryan William J (Director)	Sale	4,709	163.58	770,298
2015-05-19	Nussbaum Samuel R Md (EVP & Chief Medical Officer)	Sale	10,000	165.00	1,650,000
2015-05-19	Nussbaum Samuel R Md (EVP & Chief Medical Officer)	Option Ex	10,000	76.59	765,900
2015-05-11	Nussbaum Samuel R Md (EVP & Chief Medical Officer)	Sale	10,000	160.00	1,600,000
2015-05-11	Nussbaum Samuel R Md (EVP & Chief Medical Officer)	Option Ex	10,000	76.59	765,900
2015-04-13	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Sale	43,933	154.97	6,808,077
2015-04-13	Mccarthy Gloria M (EVP & Chief Administrative Officer)	Option Ex	43,933	64.70	2,842,333
2015-04-13	Nussbaum Samuel R Md (EVP & Chief Medical Officer)	Sale	49,340	154.68	7,631,664
2015-04-13	Nussbaum Samuel R Md (EVP & Chief Medical Officer)	Option Ex	49,340	53.34	2,632,042
2015-04-06	Deveydt Wayne S (EVP & Chief Financial Officer)	Sale	114,741	154.82	17,763,972
2015-04-06	Deveydt Wayne S (EVP & Chief Financial Officer)	Option Ex	64,885	64.06	4,156,208
2015-03-03	Gallina John E (SVP & Chief Accounting Officer)	Sale	39,555	146.03	5,776,018
2015-03-03	Gallina John E (SVP & Chief Accounting Officer)	Option Ex	33,554	72.87	2,445,012
2015-02-18	Goulet Kenneth R (EVP, Commercial & Specialty)	Sale	72,805	141.91	10,332,121
2015-02-18	Goulet Kenneth R (EVP, Commercial & Specialty)	Option Ex	72,805	70.80	5,154,594

Insider trading activities including stock purchases, stock sales, and option exercises of ELV listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Elevance Health, Inc. (symbol ELV, CIK number 1156039) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month